im3D

(Booth 1844) Italian computer-aided detection (CAD) developer im3D will officially enter the market for breast MRI CAD with the launch of CAD-Breast 1.0. The company also will show new enhancements to its CAD-Colon software.

CAD-Breast applies new automation algorithms to dynamic contrast-enhanced MRI studies to replace operations that usually are manually performed by radiologists, the Turin-based company said. These include lesion detection and segmentation, determination of hot-spot areas and most-suspect kinetic curves within a lesion, and determination of a lesion's morphologic and kinetic BI-RADS classification.

The company believes the software can significantly reduce exam reading time and interoperator variability, as well as improve diagnostic accuracy by ensuring high sensitivity, specificity, and reproducibility. The integration of diffusion-weighted images on the software will be shown as a work-in-progress.

For the company's flagship CAD-Colon software, im3D will show improvements in the CAD algorithms applied to patients with tagged feces. This should allow same-day preparation and electronic subtraction of residues and stool (with no laxatives in prep). Also, the company will show simplifications in the software's graphical user interface, better workflow, and more flexible reporting tools.